Psyence Biomedical Ltd. (PBM)
NASDAQ: PBM · Real-Time Price · USD
6.49
-0.56 (-7.94%)
At close: Apr 28, 2026, 4:00 PM EDT
6.23
-0.26 (-4.01%)
Pre-market: Apr 29, 2026, 8:02 AM EDT
Psyence Biomedical Ratios and Metrics
Market cap in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| Apr '26 Apr 28, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| Market Capitalization | 15 | 3 | 15 | 97 | 327 |
| Market Cap Growth | 627.20% | -82.20% | -84.31% | -70.26% | - |
| Enterprise Value | 8 | 2 | 15 | - | - |
| Last Close Price | 6.49 | 29.89 | 4258.98 | 39616.74 | 37396.84 |
| PE Ratio | - | 2.69 | - | - | - |
| PB Ratio | 0.16 | 0.40 | -1.39 | -485.22 | 192.35 |
| P/TBV Ratio | 1.25 | 0.40 | - | - | 192.35 |
| Debt / Equity Ratio | - | - | -0.95 | - | - |
| Net Debt / Equity Ratio | -0.60 | -0.91 | -0.88 | 6.66 | -1.03 |
| Net Debt / EBITDA Ratio | 1.73 | 1.68 | -3.53 | - | - |
| Net Debt / FCF Ratio | 1.68 | 1.64 | -3.29 | 0.84 | 1.26 |
| Quick Ratio | 7.77 | 10.55 | 0.06 | 0.83 | 13.62 |
| Current Ratio | 8.09 | 11.04 | 0.09 | 0.89 | 13.90 |
| Return on Equity (ROE) | -74.29% | - | - | -468.63% | - |
| Return on Assets (ROA) | -34.44% | -54.20% | -126.35% | -123.25% | - |
| Return on Capital Employed (ROCE) | -35.00% | -54.50% | 25.10% | 1613.80% | -109.20% |
| Earnings Yield | -26.48% | 37.25% | -335.16% | -3.30% | -0.57% |
| FCF Yield | -28.56% | -137.84% | -19.33% | -1.64% | -0.43% |
Source: S&P Capital IQ. Standard template.
Financial Sources.